Cited by 3,162Cancer Genomics and DiagnosticsCancer Cells and MetastasisEvolution and Genetic Dynamics

The DOI matches its Crossref record; 104 of the 107 references it cites were found in a registry or an index, and 3 are not checked yet.

Clonal evolution in cancer

Open access

Greaves, Mel, Maley, Carlo C.·2012·Nature

DOI 10.1038/nature10762PMC PMC3367003

Open this paper in CoChat — free account

Abstract

Cancers evolve by a reiterative process of clonal expansion, genetic diversification and clonal selection within the adaptive landscapes of tissue ecosystems. The dynamics are complex, with highly variable patterns of genetic diversity and resulting clonal architecture. Therapeutic intervention may destroy cancer clones and erode their habitats, but it can also inadvertently provide a potent selective pressure for the expansion of resistant variants. The inherently Darwinian character of cancer is the primary reason for this therapeutic failure, but it may also hold the key to more effective control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature10762

Cites

104 of 107 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Önder, T. T., Jiang, G., Tao, K. X., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,429
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253

Show all 104 references

Sorted by citations

Items 701–800 of 1,004

Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma
Chan, F. C., Mottok, A., Gerrie, A. S., Power, M. M., Nijland, M., Diepstra, A., van den Berg, A., Kamper, P., d’Amore, F., d’Amore, A. L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.7925 · Cited by 55
Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles
Casals, E., Gustà, M. F., Cobaleda‐Siles, M., García, A., & Puntes, V. (2017) · Cancer Nanotechnology · doi:10.1186/s12645-017-0030-4 · Cited by 56
Tetraploidy in cancer and its possible link to aging
Tanaka, K., Goto, H., Nishimura, Y., Kasahara, K., Mizoguchi, A., & Inagaki, M. (2018) · Cancer Science · doi:10.1111/cas.13717 · Cited by 58
The paradox of cancer genes in non-malignant conditions: implications for precision medicine
Adashek, J. J., Kato, S., Lippman, S. M., & Kurzrock, R. (2020) · Genome Medicine · doi:10.1186/s13073-020-0714-y · Cited by 59
Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors
Hayashi, M., Kuga, A., Suzuki, M., Panda, H., Kitamura, H., Motohashi, H., & Yamamoto, M. P. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2888 · Cited by 60
Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale
Barber, L. J., Davies, M. N., & Gerlinger, M. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.12.001 · Cited by 57
Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis
Carvalho, L. S. S., Gonçalves, N., Fonseca, N. A., & Moreira, J. N. (2021) · Pharmaceuticals · doi:10.3390/ph14010060 · Cited by 57
Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression
Marimuthu, S., Rauth, S., Ganguly, K., Zhang, C., Lakshmanan, I., Batra, S. K., & Ponnusamy, M. P. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09959-1 · Cited by 55
Design principles for bacteria-responsive antimicrobial nanomaterials
Quek, J. Y., Uroro, E. O., Goswami, N., & Vasilev, K. A. (2021) · Materials Today Chemistry · doi:10.1016/j.mtchem.2021.100606 · Cited by 56
A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer
Silva, F. D., & Alcorn, J. (2022) · Cancers · doi:10.3390/cancers14122954 · Cited by 58
Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma
Tamura, Y., Fujiwara, Y., Yamamoto, N., Nokihara, H., Horinouchi, H., Kanda, S., Goto, Y., Kubo, E., Kitahara, S., Tsuruoka, K., et al. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1762-z · Cited by 55
Re-Evaluating Clonal Dominance in Cancer Evolution
Burrell, R. A., & Swanton, C. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.04.002 · Cited by 54
Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia
Vesely, C., Frech, C., Eckert, C., Cario, G., Mecklenbräuker, A., Stadt, U. Z., Nebral, K., Kraler, F. A.-M., Fischer, S. H., Attarbaschi, A., et al. (2016) · Leukemia · doi:10.1038/leu.2016.365 · Cited by 55
The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia
Duployez, N., Marceau‐Renaut, A., Villenet, C., Petit, A., Rousseau, A., Ng, S., Paquet, A. C., Gonzales, F., Barthélémy, A., Leprêtre, F., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0227-5 · Cited by 53
Matched Whole-Genome Sequencing (WGS) and Whole-Exome Sequencing (WES) of Tumor Tissue with Circulating Tumor DNA (ctDNA) Analysis: Complementary Modalities in Clinical Practice
Imperial, R. J. L., Nazer, M., Ahmed, Z., Kam, A. E., Pluard, T., Bahaj, W., Levy, M. A., Kuzel, T. M., Hayden, D. M., Pappas, S. G., et al. (2019) · Cancers · doi:10.3390/cancers11091399 · Cited by 56
Leveraging Single-Cell Approaches in Cancer Precision Medicine
Nath, A., & Bild, A. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.01.007 · Cited by 57
A virome-wide clonal integration analysis platform for discovering cancer viral etiologyPreprint
Chen, X., Kost, J., Sulovari, A., Wong, N., Liang, W. S., Cao, J. P., & Li, D. (2019) · Genome Research · doi:10.1101/gr.242529.118 · Cited by 54
Cancer-Associated Mutations but No Cancer: Insights into the Early Steps of Carcinogenesis and Implications for Early Cancer Detection
Kennedy, S. R., Zhang, Y., & Risques, R. A. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.07.007 · Cited by 59
A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS–Driven Lung Cancer
Cai, H., Chew, S. K., Li, C., Tsai, M. K., Andrejka, L., Murray, C. W., Hughes, N. W., Shuldiner, E. G., Ashkin, E. L., Tang, R., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1325 · Cited by 52
Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development
Gao, W., Liu, J., Shtylla, B., Venkatakrishnan, K., Yin, D., Shah, M., Nicholas, T., & Cao, Y. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13079 · Cited by 55
Antagonistic functional duality of cancer genes
Stepanenko, A. A., Vassetzky, Y. S., & KAVSAN, V. M. (2013) · Gene · doi:10.1016/j.gene.2013.07.047 · Cited by 54
p53 orchestrates between normal differentiation and cancer
Rivlin, N., Koifman, G., & Rotter, V. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.006 · Cited by 56
CD271+ Osteosarcoma Cells Display Stem-Like Properties
Tian, J., Li, X., Si, M., Liu, T., & Li, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098549 · Cited by 54
The relationship between metastatic potential and in vitro mechanical properties of osteosarcoma cells
Holenstein, C. N., Horvath, A. N., Schär, B., Schoenenberger, A. D., Bollhalder, M., Goedecke, N., Bartalena, G., Otto, O., Herbig, M., Guck, J. R., et al. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-08-0545 · Cited by 55
Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small-Cell Lung Cancer
Han, C., Sasson, A., Srinivasan, S., Golhar, R., Greenawalt, D. M., Geese, W. J., Green, G. A., Zerba, K. E., Kirov, S. A., & Szustakowski, J. D. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00408-y · Cited by 56
Multiparametric Analysis of Longitudinal Quantitative MRI Data to Identify Distinct Tumor Habitats in Preclinical Models of Breast Cancer
Syed, A. K., Whisenant, J. G., Barnes, S. L., Sorace, A. G., & Yankeelov, T. E. (2020) · Cancers · doi:10.3390/cancers12061682 · Cited by 53
Mathematical Oncology
Anderson, A. R. A., & Maini, P. K. (2018) · Bulletin of Mathematical Biology · doi:10.1007/s11538-018-0423-5 · Cited by 55
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response
Willis, S. E., Winkler, C., Roudier, M. P., Baird, T., Marco‐Casanova, P., Jones, E. V., Rowe, P., Rodriguez‐Canales, J., Angell, H. K., Ng, F., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01560-1 · Cited by 53
Characterization of DNA Methylation in Circulating Tumor Cells
Pixberg, C., Schulz, W. A., Stoecklein, N. H., & Neves, R. P. (2015) · Genes · doi:10.3390/genes6041053 · Cited by 53
Oncogenes in melanoma: An update
Kunz, M. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.12.002 · Cited by 55
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients
Ciardiello, F., Adams, R., Tabernero, J., Seufferlein, T., Taieb, J., Moiseyenko, V., Ma, B., Lopez, G., Vansteenkiste, J. F., Esser, R., et al. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0279 · Cited by 53
Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer
Hsieh, J. J.-D., Manley, B. J., Khan, N. A., Gao, J., Carlo, M. I., & Cheng, E. H. Y. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.09.002 · Cited by 54
A population genetics perspective on the determinants of intra-tumor heterogeneity
Hu, Z., Sun, R., & Curtis, C. N. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.03.001 · Cited by 54
Genetic determinants for chemo- and radiotherapy resistance in bladder cancer
Mari, A., D’Andrea, D., Abufaraj, M. M., Foerster, B., Kimura, S., & Shariat, S. F. (2017) · Translational Andrology and Urology · doi:10.21037/tau.2017.08.19 · Cited by 53
New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis
Felsenstein, M., Hruban, R. H., & Wood, L. D. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000172 · Cited by 59
MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis
Kim, H. K., Lee, I.-K., Bang, H., Kim, H. C., Lee, W. Y., Yun, S. H., Lee, J., Lee, S. J., Park, Y. S., Kim, K., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0535 · Cited by 53
kMulti-modal meta-analysis of 1494 hepatocellular carcinoma samples reveals significant impact of consensus driver genes on phenotypes
Chaudhary, K., Poirion, O. B., Lu, L., Huang, S., Ching, T., & Garmire, L. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0088 · Cited by 48
Oncogenic activation of PI3K induces progenitor cell differentiation to suppress epidermal growth
Ying, Z., Sandoval, M., & Beronja, S. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0218-9 · Cited by 53
The Heterogeneity of Osteosarcoma: The Role Played by Cancer Stem Cells
Schiavone, K., Garnier, D., Heymann, M., & Heymann, D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-14366-4_11 · Cited by 55
Personalized targeted therapy for esophageal squamous cell carcinoma
Kang, X. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7648 · Cited by 54
FDG PET/CT-based response assessment in malignancies
Parihar, A. S., Dehdashti, F., & Wahl, R. L. (2023) · RadioGraphics · doi:10.1148/rg.220122 · Cited by 53
“A dissociated response is also seen with conventional cytotoxic therapy; this results from inherent interlesion heterogeneity, the existence of synchronous malignancies, or the treatment-induced emergence of resistant tumor clones (3,53,54).”
Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment
Yeung, T.-L., Leung, C., Li, F., Wong, S. T. C., & Mok, S. C. (2016) · Biomolecules · doi:10.3390/biom6010003 · Cited by 52
Relationship Between EGFR Expression, EGFR Mutation Status, and the Efficacy of Chemotherapy Plus Cetuximab in FLEX Study Patients with Advanced Non–Small-Cell Lung Cancer
Douillard, J., Pirker, R., O'Byrne, K. J., Kerr, K. M., Störkel, S., von Heydebreck, A., Grote, H. J., Celik, I., & Shepherd, F. A. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000141 · Cited by 53
Control of stem cells and cancer stem cells by Hedgehog signaling: Pharmacologic clues from pathway dissection
Coni, S., Infante, P., & Gulino, A. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.001 · Cited by 55
Evolutionary dynamics of the Warburg effect: Glycolysis as a collective action problem among cancer cells
Archetti, M. (2013) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2013.09.017 · Cited by 52
Toward a general evolutionary theory of oncogenesis
Ewald, P. W., & Ewald, H. A. S. (2012) · Evolutionary Applications · doi:10.1111/eva.12023 · Cited by 54
Heterogeneity of Neoplastic Stem Cells: Theoretical, Functional, and Clinical Implications
Valent, P., Bonnet, D. A., Wöhrer, S., Andreeff, M., Copland, M., Chomienne, C., & Eaves, C. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3678 · Cited by 52
Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton
Guerrero, M. S., Parsons, J. T., & Bouton, A. H. (2012) · Genes & Cancer · doi:10.1177/1947601912458585 · Cited by 52
From single-molecule detection to next-generation sequencing: microfluidic droplets for high-throughput nucleic acid analysis
Ding, Y., Choo, J., & deMello, A. J. (2017) · Microfluidics and Nanofluidics · doi:10.1007/s10404-017-1889-4 · Cited by 52
Multicolor lineage tracing reveals clonal architecture and dynamics in colon cancer
Lamprecht, S., Schmidt, E. M., Blaj, C., Hermeking, H., Jung, A., Kirchner, T., & Horst, D. A. (2017) · Nature Communications · doi:10.1038/s41467-017-00976-9 · Cited by 52
G enetic and clonal dissection of osteosarcoma progression and lung metastasis
Xu, H., Zhu, X., Bao, H., Shek, T. W., Huang, Z., Wang, Y., Wu, X., Wu, Y., Chang, Z., Wu, S., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31389 · Cited by 51
Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development
Sterzyńska, K., Klejewski, A., Wojtowicz, K., Świerczewska, M., Nowacka, M., Kaźmierczak, D., Andrzejewska, M., Rusek, D., Brązert, M., Brązert, J., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010054 · Cited by 52
Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome
Watanabe, K. (2018) · Pediatrics International · doi:10.1111/ped.13776 · Cited by 52
The role of clonal communication and heterogeneity in breast cancer
Martín-Pardillos, A., Valls‐Chiva, A., Vargas, G. B., Hurtado, P., Piñeiro, R., Guijarro-Carrillo, P. J., Hümmer, S., Serrano, E., Rodríguez‐Casanova, A., Díaz‐Lagares, Á., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5883-y · Cited by 52
A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integration
Schürch, C. M., Rasche, L., Frauenfeld, L., Weinhold, N., & Fend, F. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02725-3 · Cited by 58
Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?
Klotz, D. M., & Wimberger, P. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05677-1 · Cited by 54
Big Bang Tumor Growth and Clonal EvolutionPreprint
Sun, R., Hu, Z., & Curtis, C. N. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028381 · Cited by 61
Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments
Mundi, P. S., Dela Cruz, F. S., Grunn, A., Diolaiti, D., Mauguen, A., Rainey, A. R., Guillan, K. C., Siddiquee, A., You, D., Realubit, R., et al. (2021) · doi:10.1101/2021.10.03.462951 · Cited by 51
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer
Magnani, L., Patten, D. K., Nguyen, V. T. M., Hong, S.-P., Steel, J. H., Patel, N. R., Lombardo, Y., Faronato, M., Gomes, A., Woodley, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4243 · Cited by 50
Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and “swarm intelligence”
Tarabichi, M., Antoniou, A., Saiselet, M., Pita, J. M. G., Andry, G., Dumont, J. E., Detours, V., & Maenhaut, C. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9431-y · Cited by 51
C ancer stem cells: A product of clonal evolution?
van Niekerk, G., Davids, L. M., Hattingh, S. M., & Engelbrecht, A. (2016) · International Journal of Cancer · doi:10.1002/ijc.30448 · Cited by 52
Mcl-1 inhibitors: a patent review
Chen, L., & Fletcher, S. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1249848 · Cited by 51
High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer
Jeantet, M., Tougeron, D., Tachon, G., Cortes, U., Archambaut, C., Fromont, G., & Karayan, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122015 · Cited by 51
Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development
Dzobo, K., Senthebane, D. A., Thomford, N. E., Rowe, A., Dandara, C., & Parker, M. I. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0174 · Cited by 54
Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms
Chaurasiya, S., Chen, N. G., & Warner, S. G. (2018) · Cancers · doi:10.3390/cancers10040124 · Cited by 55
Towards a heterarchical approach to biology and cognition
Bruni, L. E., & Giorgi, F. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.07.005 · Cited by 50
On the interplay between mathematics and biology
Bellomo, N., Elaiw, A. M., Althiabi, A. M., & Alghamdi, M. (2014) · Physics of Life Reviews · doi:10.1016/j.plrev.2014.12.002 · Cited by 50
The evolution of failure: explaining cancer as an evolutionary process
Lean, C. H., & Plutynski, A. (2015) · Biology & Philosophy · doi:10.1007/s10539-015-9511-1 · Cited by 56
Model genotype–phenotype mappings and the algorithmic structure of evolution
Nichol, D., Robertson‐Tessi, M., Anderson, A. R. A., & Jeavons, P. (2019) · Journal of The Royal Society Interface · doi:10.1098/rsif.2019.0332 · Cited by 63
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
Li, A., Keck, J. M., Parmar, S. S., Patterson, J., Labrie, M., Creason, A., Johnson, B., Downey, M., THOMAS, G. V., Beadling, C., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00165-4 · Cited by 53
Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics
健次, 平., & Wang, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1125174 · Cited by 53
CD200 ectodomain shedding into the tumor microenvironment leads to NK cell dysfunction and apoptosis
Morgan, H. J., Rees, E., Lanfredini, S., Powell, K. A., Gore, J., Gibbs, A., Lovatt, C., Davies, G. E., Olivero, C., Shorning, B. Y., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci150750 · Cited by 52
Learning to distinguish progressive and non-progressive ductal carcinoma in situ
Casasent, T. D., Almekinders, M. M., Mulder, C., Bhattacharjee, P., Collyar, D. E., Thompson, A. M., Jonkers, J., Lips, E. H., van Rheenen, J., Hwang, E. S., et al. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00512-y · Cited by 50
Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease
Sawyer, J. R., Tian, E., Heuck, C. J., Epstein, J., Johann, D. J., Swanson, C. M., Lukacs, J. L., Johnson, M., Binz, R. L., Boast, A., et al. (2014) · Blood · doi:10.1182/blood-2013-12-546077 · Cited by 50
The structural basis for cancer treatment decisions
Nussinov, R., Jang, H., & Tsai, C. (2014) · Oncotarget · doi:10.18632/oncotarget.2439 · Cited by 51
Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
Markiewicz, A., Ahrends, T., Wełnicka-Jaśkiewicz, M., Seroczyńska, B., Skokowski, J., Jaśkiewicz, J., Szade, J., Biernat, W., & Zaczek, A. J. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-226 · Cited by 50
Modulatory effect of Pleurotus ostreatus on oxidant/antioxidant status in 7, 12-dimethylbenz (a) anthracene induced mammary carcinoma in experimental rats - A dose-response study
sankaran, M., & Deepalakshmi, K. (2016) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.148691 · Cited by 50
Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer
Suman, S., Basak, T., Gupta, P., Mishra, S., Kumar, V., Sengupta, S., & Shukla, Y. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.07.033 · Cited by 50
Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma
Vinayanuwattikun, C., Calvez‐Kelm, F. L., Abedi‐Ardekani, B., Zaridze, D. G., Mukeria, A., Voegele, C., Vallée, M., Purnomosari, D., Forey, N., Durand, G., et al. (2016) · Scientific Reports · doi:10.1038/srep31628 · Cited by 49
Cancer cell transmission via the placenta
Greaves, M. F., & Hughes, W. O. H. (2018) · Evolution Medicine and Public Health · doi:10.1093/emph/eoy011 · Cited by 52
Self-citation
Consecutive seeding and transfer of genetic diversity in metastasis
Heyde, A., Reiter, J. G., Naxerova, K., & Nowak, M. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819408116 · Cited by 45
Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology
Akhtar, M., Hyassat, S. A., Elaiwy, O., Rashid, S., & Al-Nabet, A. D. M. H. (2019) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000251 · Cited by 50
Proteomics and its applications in breast cancer.
Neagu, A.-N., Whitham, D., Buonanno, E., Jenkins, A., Alexa‐Stratulat, T., Tamba, B.-I., & Darie, C. C. (2021) · PubMed Central · Cited by 48
Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid Leukemia
Guess, T. E., Potts, C. R., Bhat, P., Cartailler, J. A., Brooks, A., Holt, C., Yenamandra, A., Wheeler, F. C., Savona, M. R., Cartailler, J.-P., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0128 · Cited by 50
The pharmacological point of view of resistance to therapy in tumors
Damia, G. L. M., & Garattini, S. K. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.05.008 · Cited by 48
Changes of heterogeneous cell populations in the Ishikawa cell line during long-term culture: Proposal for an in vitro clonal evolution model of tumor cells
Kasai, F., Hirayama, N., Ozawa, M., Iemura, M., & Kohara, A. (2016) · Genomics · doi:10.1016/j.ygeno.2016.04.003 · Cited by 49
Optical Barcoding for Single-Clone Tracking to Study Tumor Heterogeneity
Mohme, M., Maire, C. L., Riecken, K., Zapf, S., Aranyossy, T., Westphal, M., Lamszus, K., & Fehse, B. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.12.014 · Cited by 49
Ancient genes establish stress-induced mutation as a hallmark of cancer
Cisneros, L. H., Bussey, K. J., Orr, A. J., Miočević, M., Lineweaver, C. H., & Davies, P. C. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176258 · Cited by 49
Targeting Acidic Diseased Tissues by pH-Triggered Membrane-Associated Peptide Folding
Reshetnyak, Y. K., Moshnikova, A., Andreev, O. A., & Engelman, D. M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00335 · Cited by 50
Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells
Saki, M. R., Toulany, M., & Rodemann, H. P. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.023 · Cited by 48
Mechanisms of Resistance to Intermittent Androgen Deprivation in Patients with Prostate Cancer Identified by a Novel Computational Method
Morken, J. D., Packer, A., Everett, R. A., Nagy, J. D., & Kuang, Y. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3162 · Cited by 47
The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells
Zanetti, M., Rodvold, J. J., & Mahadevan, N. R. (2015) · Oncogene · doi:10.1038/onc.2015.108 · Cited by 49
Single-Cell Genetic Analysis Using Automated Microfluidics to Resolve Somatic Mosaicism
Szulwach, K. E., Chen, P., Wang, X., Wang, J., Weaver, L. S., Gonzales, M. L., Sun, G., Unger, M., & Ramakrishnan, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135007 · Cited by 47
TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24− cancer cells
Pal, D., Pertot, A., Shirole, N. H., Yao, Z., Anaparthy, N., Garvin, T. H., Cox, H., Chang, K., Rollins, F., Kendall, J., et al. (2017) · eLife · doi:10.7554/elife.21615 · Cited by 50
Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
Macpherson, A. M., Barry, S. C., Ricciardelli, C., & Oehler, M. K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092967 · Cited by 51
Beyond Perfect Phylogeny
Bonizzoni, P., Ciccolella, S., Vedova, G. D., & Soto, M. (2017) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/3107411.3107441 · Cited by 47
Tracking cells in epithelial acini by light sheet microscopy reveals proximity effects in breast cancer initiation
Alladin, A., Chaible, L. M., del Valle, L. G., Reither, S., Löschinger, M., Wachsmuth, M., Hèriché, J.-K., Tischer, C., & Jechlinger, M. (2020) · eLife · doi:10.7554/elife.54066 · Cited by 50
Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance
Tabatabaee, A., Nafari, B., Farhang, A., Hariri, A., Khosravi, A., Zarrabi, A., & Mirian, M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10154-7 · Cited by 48
The war on cancer: are we winning?
Duffy, M. J. (2013) · Tumor Biology · doi:10.1007/s13277-013-0759-2 · Cited by 47
Adaptation and learning of molecular networks as a description of cancer development at the systems-level: Potential use in anti-cancer therapies
Gyurkó, D. M., Veres, D. V., Módos, D., Lenti, K., Korcsmáros, T., & Csermely, P. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.06.005 · Cited by 50

Authors: Greaves, M., & Maley, C. C.
Affiliations: University of California, San Francisco (US)
ORCID: Maley, Carlo C.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2012-01
Volume: 481
Issue: 7381
Pages: 306-313
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10762
PMC: PMC3367003
OpenAlex: W2023560061
Cited by: 3,162
References: 104
Citations by year: 2026: 180 · 2025: 160 · 2024: 181 · 2023: 225 · 2022: 204 · 2021: 253 · 2020: 229 · 2019: 211 · 2018: 247 · 2017: 296 · 2016: 247 · 2015: 238 · 2014: 221 · 2013: 164 · 2012: 101
FWCI: 17.27
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Cancer Institute (R01CA149566, P01CA091955, U54CA143803, P01CA91955, R01CA140657)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords: clonal evolution, cancer, clonal expansion, genetic diversification, clonal selection, fitness landscape, tumor microenvironment, clonal architecture, drug resistance
MeSH terms: Animals, Clone Cells, Humans, Mutation, Neoplasms, Neoplastic Stem Cells, Genomics, Tumor Microenvironment, Clonal Evolution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clonal evolution in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks